E-LIB Suche - Ergebnisse für: Bull, Matthew R

1

Design and Biological Evaluation of Piperazine-Bearing Nitr..:

Ashoorzadeh, Amir ; Mowday, Alexandra M. ; Abbattista, Maria R....
ACS Medicinal Chemistry Letters. 14 (2023) 11 - p. 1517-1523 , 2023

Link: https://doi.org/10.1021/..

2

Tissue Pharmacokinetic Properties and Bystander Potential o..:

Jackson-Patel, Victoria ; Liu, Emily ; Bull, Matthew R....
Frontiers in Pharmacology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

3

Preclinical Activity and Pharmacokinetic/Pharmacodynamic Re..:

Gartlan, Kate H. ; Jaiswal, Jagdish K. ; Bull, Matthew R....
ACS Pharmacology & Translational Science. 5 (2022) 6 - p. 429-439 , 2022

Link: https://doi.org/10.1021/..

4

Interrogation of the Structure–Activity Relationship of a L..:

Ashoorzadeh, Amir ; Mowday, Alexandra M. ; Guise, Christopher P....
Pharmaceuticals. 15 (2022) 2 - p. 185 , 2022

Link: https://doi.org/10.3390/..

5

Restoring Tumour Selectivity of the Bioreductive Prodrug PR..:

Abbattista, Maria R. ; Ashoorzadeh, Amir ; Guise, Christopher P....
Pharmaceuticals. 14 (2021) 12 - p. 1231 , 2021

Link: https://doi.org/10.3390/..

6

Selectively Targeting Tumor Hypoxia With the Hypoxia-Activa..:

van der Wiel, Alexander M.A. ; Jackson-Patel, Victoria ; Niemans, Raymon...
Molecular Cancer Therapeutics. 20 (2021) 12 - p. 2372-2383 , 2021

Link: https://doi.org/10.1158/..

7

Inhibition of the Cytolytic Protein Perforin Prevents Rejec..:

Spicer, Julie A. ; Miller, Christian K. ; O'Connor, Patrick D....
Journal of Medicinal Chemistry. 63 (2019) 5 - p. 2229-2239 , 2019

Link: https://doi.org/10.1021/..

8

Rational design of an AKR1C3-resistant analog of PR-104 for..:

Mowday, Alexandra M. ; Ashoorzadeh, Amir ; Williams, Elsie M....
Biochemical Pharmacology. 116 (2016) - p. 176-187 , 2016

Link: https://doi.org/10.1016/..

9

Tissue Pharmacokinetic Properties and Bystander Potential o..:

Jackson-Patel, Victoria ; Liu, Emily ; Bull, Matthew R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861431/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Preclinical Activity and Pharmacokinetic/Pharmacodynamic Re..:

Gartlan, Kate H ; Jaiswal, Jagdish K ; Bull, Matthew R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194936/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Selectively Targeting Tumor Hypoxia With the Hypoxia-Activa..:

van der Wiel, Alexander M.A ; Jackson-Patel, Victoria ; Niemans, Raymon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398139/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Selectively Targeting Tumor Hypoxia with the Hypoxia-Activa..:

van der Wiel, Alexander M A ; Jackson-Patel, Victoria ; Niemans, Raymon...
van der Wiel , A M A , Jackson-Patel , V , Niemans , R , Yaromina , A , Liu , E , Marcus , D , Mowday , A M , Lieuwes , N G , Biemans , R , Lin , X , Fu , Z , Kumara , S , Jochems , A , Ashoorzadeh , A , Anderson , R F , Hicks , K O , Bull , M R , Abbattista , M R , Guise , C P , Deschoemaeker , S , Thiolloy , S , Heyerick , A , Solivio , M J , Balbo , S , Smaill , J B , Theys , J , Dubois , L J , Patterson , A V & Lambin , P 2021 , ' Selectively Targeting Tumor Hypoxia with the Hypoxia-Activated Prodrug CP-506 ' , Molecular Cancer Therapeutics , vol. 20 , no. 12 , pp. 2372-2383 . https://doi.org/10.1158/1535-7163.MCT-21-0406. , 2021

Link: https://cris.maastrichtu..

13